PG-530742 - Procter & Gamble
sprifermin (AS-902330) - TrialSpark
Raylumis (tanezumab) - Eli Lilly, Pfizer
Humira (adalimumab) - Eisai, AbbVie
lorecivivint (SM04690) - Biosplice Therap, Samil Pharma
Xeljanz (tofacitinib) - Pfizer
Kineret (anakinra) - SOBI
AMG 108 - AstraZeneca
doxycycline - Generic mfg.
cindunistat (SC84250) - Pfizer
QUC398 - Novartis
Enbrel (etanercept) - Pfizer, Amgen
http://www.ncbi.nlm.nih.gov/pubmed/36793668
 
Feb 17, 2023